<?xml version="1.0" encoding="iso-8859-1"?>
<frameset>
<predicate lemma="alter">
<roleset id="alter.01" name="" wordnet="1">
<roles>
  <role n="0" descr="causer of transformation		// mutation, protein //
"/>
  <role n="1" descr="thing changing				// codon, exon, premRNA //
"/>
  <role n="2" descr="end state				
"/>
  <role n="3" descr="start state				
"/>
  <role n="4" descr="location refering to tissue, organelle, person, gene
"/>
</roles>
<example src="MEDLINE" no="1">
<text>
Mutations that alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.

</text>
       <arg n="0">mutations
</arg>
       <arg n="1">splice sites
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
<fdg>
         1	Mutations	mutation	subj:&gt;6	@SUBJ %NH N NOM PL
         2	that	that	subj:&gt;3	@SUBJ %NH &lt;Rel&gt; PRON
         3	alter	alter	mod:&gt;1	@+FMAINV %VA V PRES
         4	splice	splice	attr:&gt;5	@A&gt; %&gt;N N NOM SG
         5	sites	site	obj:&gt;3	@OBJ %NH N NOM PL
         6	led	lead		@+FMAINV %VA V PAST
         7	to	to	ha:&gt;6	@ADVL %EH PREP
         8	the	the	det:&gt;9	@DN&gt; %&gt;N DET
         9	synthesis	synthesis	pcomp:&gt;7	@&lt;P %NH N NOM SG
         10	of	of	mod:&gt;9	@&lt;NOM-OF %N&lt; PREP
         11	several	several	det:&gt;12	@DN&gt; %&gt;N DET PL
         12	types	type	pcomp:&gt;10	@&lt;P %NH N NOM PL
         13	of	of	mod:&gt;12	@&lt;NOM-OF %N&lt; PREP
         14	mRNAs	mrna	pcomp:&gt;13	@&lt;P %NH &lt;?&gt; N NOM PL
         15	,	,
         16	a	a	det:&gt;17	@DN&gt; %&gt;N DET SG
         17	fraction	fraction	subj:&gt;20	@SUBJ %NH N NOM SG
         18	of	of	mod:&gt;17	@&lt;NOM-OF %N&lt; PREP
         19	which	which	pcomp:&gt;18	@&lt;P %NH &lt;Rel&gt; PRON WH NOM
         20	represented	represent		@+FMAINV %VA V PAST
         21	the	the	det:&gt;24	@DN&gt; %&gt;N DET
         22	normally	normally	ad:&gt;23	@AD-A&gt; %E&gt; ADV
         23	spliced	spliced	attr:&gt;24	@A&gt; %&gt;N A ABS
         24	product	product	obj:&gt;20	@OBJ %NH N NOM SG
         25	.     .
</fdg>
</example>
<example src="MEDLINE" no="2">
<text>
In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.

</text>
       <arg n="0">splice variations
</arg>
       <arg n="1">the protein product
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
<fdg>
         1	In	in		@ADVL %EH PREP
         2	protein-coding	protein-coding	attr:&gt;3	@A&gt; %&gt;N &lt;?&gt; A ABS
         3	transcripts	transcript	pcomp:&gt;1	@&lt;P %NH N NOM PL
         4	,	,
         5	79%	79%	mod:&gt;3	@APP %NH NUM CARD
         6	of	of	mod:&gt;5	@&lt;NOM-OF %N&lt; PREP
         7	splice	splice	attr:&gt;8	@A&gt; %&gt;N N NOM SG
         8	variations	variation	pcomp:&gt;6	@&lt;P %NH N NOM PL
         9	altered	alter	main:&gt;0	@+FMAINV %VA V PAST
         10	the	the	det:&gt;12	@DN&gt; %&gt;N DET
         11	protein	protein	attr:&gt;12	@A&gt; %&gt;N N NOM SG
         12	product	product	obj:&gt;9	@OBJ %NH N NOM SG
         13	.     .
</fdg>
</example>
<example src="MEDLINE" no="3">
<text>
Four other mutations alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.

</text>
       <arg n="0">Four other mutations
</arg>
       <arg n="1">either the conserved gt or ag dinucleotide splice sites
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">[in] the IVD gene
</arg>
<fdg>
         1	Four	four	qn:&gt;2	@QN&gt; %&gt;N NUM CARD
         2	other	other	det:&gt;3	@DN&gt; %&gt;N DET
         3	mutations	mutation	subj:&gt;4	@SUBJ %NH N NOM PL
         4	alter	alter	main:&gt;0	@+FMAINV %VA V PRES
         5	either	either	meta:&gt;4	@ADVL %EH ADV
         6	the	the	det:&gt;8	@DN&gt; %&gt;N DET
         7	conserved	conserved	attr:&gt;8	@A&gt; %&gt;N A ABS
         8	gt	gt	obj:&gt;4	@OBJ %NH ABBR NOM SG
         9	or	or	cc:&gt;8	@CC %CC CC
         10	ag	ag	attr:&gt;11	@A&gt; %&gt;N N NOM SG
         11	dinucleotide	dinucleotide	attr:&gt;12	@A&gt; %&gt;N N NOM SG
         12	splice	splice	attr:&gt;13	@A&gt; %&gt;N N NOM SG
         13	sites	site	cc:&gt;8	@OBJ %NH N NOM PL
         14	in	in	loc:&gt;4	@ADVL %EH PREP
         15	the	the	det:&gt;17	@DN&gt; %&gt;N DET
         16	IVD	ivd	attr:&gt;17	@A&gt; %&gt;N N NOM SG
         17	gene	gene	pcomp:&gt;14	@&lt;P %NH N NOM SG
         18	.     .
</fdg>
</example>
<example src="MEDLINE" no="4">
<text>
This mutation is located within exon 2 and alters the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes.

</text>
       <arg n="0">This mutation
</arg>
       <arg n="1">the codon
</arg>
       <arg n="2">to a codon (CAC)
</arg>
       <arg n="3">the codon (CTC) 
</arg>
       <arg n="4">-
</arg>
<fdg>
         1	This	this	det:&gt;2	@DN&gt; %&gt;N DET DEM SG
         2	mutation	mutation	subj:&gt;3	@SUBJ %NH N NOM SG
         3	is	be	v-ch:&gt;4	@+FAUXV %AUX V PRES SG3
         4	located	locate	main:&gt;0	@-FMAINV %VP EN
         5	within	within	ha:&gt;4	@ADVL %EH PREP
         6	exon	exon	attr:&gt;7	@A&gt; %&gt;N N NOM SG
         7	2	2	pcomp:&gt;5	@&lt;P %NH NUM CARD
         8	and	and	cc:&gt;4	@CC %CC CC
         9	alters	alter	cc:&gt;4	@+FMAINV %VA V PRES SG3
         10	the	the	det:&gt;11	@DN&gt; %&gt;N DET
         11	codon	codon	obj:&gt;9	@OBJ %NH N NOM SG
         12	(	(
         13	CTC	ctc	mod:&gt;11	@NH %NH ABBR NOM SG
         14	)	)
         15	normally	normally	frq:&gt;9	@ADVL %EH ADV
         16	associated	associate		@-FMAINV %VP EN
         17	with	with	phr:&gt;16	@ADVL %EH PREP
         18	Leu-93	leu-93	pcomp:&gt;17	@&lt;P %NH &lt;?&gt; NUM CARD
         19	in	in	mod:&gt;18	@&lt;NOM %N&lt; PREP
         20	the	the	det:&gt;22	@DN&gt; %&gt;N DET
         21	transcortin	transcortin	attr:&gt;22	@A&gt; %&gt;N &lt;?&gt; N NOM SG
         22	polypeptide	polypeptide	pcomp:&gt;19	@&lt;P %NH N NOM SG
         23	to	to		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
         24	a	a	det:&gt;25	@DN&gt; %&gt;N DET SG
         25	codon	codon	pcomp:&gt;23	@&lt;P %NH N NOM SG
         26	(	(
         27	CAC	cac	mod:&gt;25	@NH %NH ABBR NOM SG
         28	)	)
         29	for	for		@ADVL %EH PREP
         30	histidine	histidine	pcomp:&gt;29	@&lt;P %NH &lt;?&gt; N NOM SG
         31	in	in	mod:&gt;30	@&lt;NOM %N&lt; PREP
         32	the	the	det:&gt;34	@DN&gt; %&gt;N DET
         33	variant	variant	attr:&gt;34	@A&gt; %&gt;N N NOM SG
         34	genes	gene	pcomp:&gt;31	@&lt;P %NH N NOM PL
         35	.     .
</fdg>
</example>
<example src="MEDLINE" no="5">
<text>
Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.

</text>
       <arg n="0">Cytokines
</arg>
       <arg n="1">the expression and activity of the multidrug resistance transporters
</arg>
       <arg n="2">- 
</arg>
       <arg n="3">- 
</arg>
       <arg n="4">[in] human hepatoma cell lines
</arg>
<fdg>
1	Cytokines	cytokine	subj:&gt;2	@SUBJ %NH N NOM PL
2	alter	alter	main:&gt;0	@+FMAINV %VA V PRES
3	the	the	det:&gt;4	@DN&gt; %&gt;N DET
4	expression	expression	obj:&gt;2	@OBJ %NH N NOM SG
5	and	and	cc:&gt;4	@CC %CC CC
6	activity	activity	cc:&gt;4	@OBJ %NH N NOM SG
7	of	of	mod:&gt;6	@&lt;NOM-OF %N&lt; PREP
8	the	the	det:&gt;11	@DN&gt; %&gt;N DET
9	multidrug	multidrug	attr:&gt;10	@A&gt; %&gt;N A ABS
10	resistance	resistance	attr:&gt;11	@A&gt; %&gt;N N NOM SG
11	transporters	transporter	pcomp:&gt;7	@&lt;P %NH N NOM PL
12	in	in	mod:&gt;11	@&lt;NOM %N&lt; PREP
13	human	human	attr:&gt;14	@A&gt; %&gt;N A ABS
14	hepatoma	hepatoma	attr:&gt;15	@A&gt; %&gt;N &lt;?&gt; N NOM SG
15	cell	cell	attr:&gt;16	@A&gt; %&gt;N N NOM SG
16	lines	line	pcomp:&gt;12	@&lt;P %NH N NOM PL
17	;	;
18	analysis	analysis	mod:&gt;16	@NH %NH N NOM SG
19	using	use		@&lt;P-FMAINV %VA ING	@-FMAINV %VA ING
20	RT-PCR	rt-pcr	cc:&gt;22	@A&gt; %&gt;N N NOM SG
21	and	and	cc:&gt;22	@CC %CC CC
22	cDNA	cdna	attr:&gt;23	@A&gt; %&gt;N ABBR NOM SG
23	microarrays	microarray	obj:&gt;19	@OBJ %NH &lt;?&gt; N NOM PL
24	.     .
</fdg>
</example>
<example src="EMBO" no="1">
<text>
Since these two bends are in opposing directions, they do not alter the overall direction of the DNA(Figure 3C).

</text>
       <arg n="0">they
</arg>
       <arg n="1">the overall direction of the DNA
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
       <arg n="M-NEG">not
</arg>
<fdg>

1	Since	since	pm:&gt;5	@CS %CS CS
2	these	this	det:&gt;4	@DN&gt; %&gt;N DET DEM PL
3	two	two	qn:&gt;4	@QN&gt; %&gt;N NUM CARD
4	bends	bend	subj:&gt;5	@SUBJ %NH N NOM PL
5	are	be	cnt:&gt;13	@+FMAINV %VA V PRES
6	in	in	ha:&gt;5	@ADVL %EH PREP
7	opposing	oppose	pcomp:&gt;6	@&lt;P-FMAINV %VA ING
8	directions	direction	obj:&gt;7	@OBJ %NH N NOM PL
9	,	,
10	they	they	subj:&gt;11	@SUBJ %NH PRON PERS NOM PL3
11	do	do	v-ch:&gt;13	@+FAUXV %AUX V PRES
12	not	not	neg:&gt;11	@ADVL %EH NEG-PART
13	alter	alter	main:&gt;0	@-FMAINV %VA V INF
14	the	the	det:&gt;16	@DN&gt; %&gt;N DET
15	overall	overall	attr:&gt;16	@A&gt; %&gt;N A ABS
16	direction	direction	obj:&gt;13	@OBJ %NH N NOM SG
17	of	of	mod:&gt;16	@&lt;NOM-OF %N&lt; PREP
18	the	the	det:&gt;19	@DN&gt; %&gt;N DET
19	DNA	dna	pcomp:&gt;17	@&lt;P %NH ABBR NOM SG
20	(	(
21	Figure	figure	attr:&gt;22	@A&gt; %&gt;N N NOM SG
22	3C	3c		@NH %NH NUM CARD	@APP %NH NUM CARD	@A&gt; %&gt;N NUM CARD
23	)	)
24	.     .
</fdg>
</example>
<example src="EMBO" no="2">
<text>
Hence, Glu13 indirectly affects DNA-binding specificity, probably due to the change in DNA conformation, which subtly alters the specific protein DNA interactions observed.

</text>
       <arg n="0">the change in DNA conformation
</arg>
       <arg n="1">specific protein DNA interactions observed
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
<fdg>
1	Hence	hence	meta:&gt;5	@ADVL %EH ADV
2	,	,
3	Glu13	glu13	subj:&gt;5	@SUBJ %NH N NOM SG
4	indirectly	indirectly	man:&gt;5	@ADVL %EH ADV
5	affects	affect	main:&gt;0	@+FMAINV %VA V PRES SG3
6	DNA-binding	dna-binding	attr:&gt;7	@A&gt; %&gt;N N NOM SG
7	specificity	specificity	obj:&gt;5	@OBJ %NH N NOM SG
8	,	,
9	probably	probably	ad:&gt;10	@AD-A&gt; %E&gt; ADV
10	due to	due to		@ADVL %EH PREP
11	the	the	det:&gt;12	@DN&gt; %&gt;N DET
12	change	change	pcomp:&gt;10	@&lt;P %NH N NOM SG
13	in	in	mod:&gt;12	@&lt;NOM %N&lt; PREP
14	DNA	dna	attr:&gt;15	@A&gt; %&gt;N ABBR NOM SG
15	conformation	conformation	pcomp:&gt;13	@&lt;P %NH N NOM SG
16	,	,
17	which	which	subj:&gt;19	@SUBJ %NH &lt;Rel&gt; PRON WH NOM
18	subtly	subtly	man:&gt;19	@ADVL %EH ADV
19	alters	alter	mod:&gt;15	@+FMAINV %VA V PRES SG3
20	the	the	det:&gt;22	@DN&gt; %&gt;N DET
21	specific	specific	attr:&gt;22	@A&gt; %&gt;N A ABS
22	protein	protein	obj:&gt;19	@OBJ %NH N NOM SG
23	&amp;	    &amp;		@CC %CC CC
24	#8211	#8211		@SUBJ %NH NUM CARD	@OBJ %NH NUM CARD	@&lt;NOM %N&lt; NUM CARD	@ADVL %EH NUM CARD
25	;	;
26	DNA	dna	attr:&gt;27	@A&gt; %&gt;N ABBR NOM SG
27	interactions	interaction	subj:&gt;28	@SUBJ %NH N NOM PL
28	observed	observe	cc:&gt;19	@+FMAINV %VA V PAST
29	.     .
</fdg>
</example>
<example src="EMBO" no="3">
<text>
Phosphorylation of PDK1 was not altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.

</text>
       <arg n="0">treating the cells with insulin-like growth factor-I
</arg>
       <arg n="1">Phosphorylation of PDK1
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
       <arg n="M-NEG">not
</arg>
<fdg>
1	Phosphorylation	phosphorylation	subj:&gt;4	@SUBJ %NH N NOM SG
2	of	of	mod:&gt;1	@&lt;NOM-OF %N&lt; PREP
3	PDK1	pdk1	pcomp:&gt;2	@&lt;P %NH N NOM SG
4	was	be	v-ch:&gt;6	@+FAUXV %AUX V PAST
5	not	not	neg:&gt;4	@ADVL %EH NEG-PART
6	altered	alter		@-FMAINV %VP EN
7	by	by	man:&gt;6	@ADVL %EH PREP
8	treating	treat	pcomp:&gt;7	@&lt;P-FMAINV %VA ING
9	the	the	det:&gt;10	@DN&gt; %&gt;N DET
10	cells	cell	obj:&gt;8	@OBJ %NH N NOM PL
11	with	with		@&lt;NOM %N&lt; PREP	@ADVL %EH PREP
12	insulin-like	insulin-like	attr:&gt;13	@A&gt; %&gt;N A ABS
13	growth	growth	attr:&gt;14	@A&gt; %&gt;N N NOM SG
14	factor-I	factor-i	pcomp:&gt;11	@&lt;P %NH &lt;?&gt; N NOM SG
15	and	and	cc:&gt;14	@CC %CC CC
16	four	four	cc:&gt;14	@&lt;P %NH NUM CARD
17	of	of	mod:&gt;16	@&lt;NOM-OF %N&lt; PREP
18	the	the	det:&gt;19	@DN&gt; %&gt;N DET
19	sites	site	pcomp:&gt;17	@&lt;P %NH N NOM PL
20	could	could	v-ch:&gt;21	@+FAUXV %AUX V AUXMOD
21	be	be	v-ch:&gt;22	@-FAUXV %AUX V INF
22	mutated	mutate		@-FMAINV %VP EN
23	without	without	ha:&gt;22	@ADVL %EH PREP
24	loss	loss	pcomp:&gt;23	@&lt;P %NH N NOM SG
25	of	of	mod:&gt;24	@&lt;NOM-OF %N&lt; PREP
26	activity	activity	pcomp:&gt;25	@&lt;P %NH N NOM SG
27	.     .
</fdg>
</example>
<example src="EMBO" no="4">
<text>
As the molecular lesion associated with s1031 is predicted to alter splicing, we looked at the sos-1 mRNA produced in this mutant.

</text>
       <arg n="0">the molecular lesion associated with s1031
</arg>
       <arg n="1">splicing 
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
<fdg>
8	As	as	pm:&gt;16	@CS %CS CS
9	the	the	det:&gt;11	@DN&gt; %&gt;N DET
10	molecular	molecular	attr:&gt;11	@A&gt; %&gt;N A ABS
11	lesion	lesion	subj:&gt;15	@SUBJ %NH N NOM SG
12	associated	associate	mod:&gt;11	@-FMAINV %VP EN
13	with	with	phr:&gt;12	@ADVL %EH PREP
14	s1031	s1031	pcomp:&gt;13	@&lt;P %NH N NOM SG
15	is	be	v-ch:&gt;16	@+FAUXV %AUX V PRES SG3
16	predicted	predict	man:&gt;2	@-FMAINV %VP EN
17	to	to	pm:&gt;18	@INFMARK&gt; %AUX INFMARK&gt;
18	alter	alter	cnt:&gt;16	@-FMAINV %VA V INF
19	splicing	splicing	obj:&gt;18	@OBJ %NH A ABS
20	,	,
21	we	we	subj:&gt;22	@SUBJ %NH PRON PERS NOM PL1
22	looked	look		@+FMAINV %VA V PAST
23	at	at	ha:&gt;22	@ADVL %EH PREP
24	the	the	det:&gt;26	@DN&gt; %&gt;N DET
25	sos-1	sos-1	qn:&gt;26	@QN&gt; %&gt;N &lt;?&gt; NUM CARD
26	mRNA	mrna	pcomp:&gt;23	@&lt;P %NH ABBR NOM SG
27	produced	produce	mod:&gt;26	@-FMAINV %VP EN
28	in	in	ha:&gt;27	@ADVL %EH PREP
29	this	this	det:&gt;30	@DN&gt; %&gt;N DET DEM SG
30	mutant	mutant	pcomp:&gt;28	@&lt;P %NH N NOM SG
31	.     .
</fdg>
</example>
<example src="EMBO" no="5">
<text>
Since s1031 is a null allele, we tested whether this mutation alters vulval induction.

</text>
       <arg n="0">this mutation 
</arg>
       <arg n="1">vulval induction 
</arg>
       <arg n="2">-
</arg>
       <arg n="3">-
</arg>
       <arg n="4">-
</arg>
<fdg>
1	Since	since	pm:&gt;3	@CS %CS CS
2	s1031	s1031	subj:&gt;3	@SUBJ %NH N NOM SG
3	is	be	cnt:&gt;9	@+FMAINV %VA V PRES SG3
4	a	a	det:&gt;6	@DN&gt; %&gt;N DET SG
5	null	null	attr:&gt;6	@A&gt; %&gt;N N NOM SG
6	allele	allele	comp:&gt;3	@PCOMPL-S %NH N NOM SG
7	,	,
8	we	we	subj:&gt;9	@SUBJ %NH PRON PERS NOM PL1
9	tested	test	main:&gt;0	@+FMAINV %VA V PAST
10	whether	whether	pm:&gt;13	@CS %CS CS
11	this	this	det:&gt;12	@DN&gt; %&gt;N DET DEM SG
12	mutation	mutation	subj:&gt;13	@SUBJ %NH N NOM SG
13	alters	alter	obj:&gt;9	@+FMAINV %VA V PRES SG3
14	vulval	vulval	attr:&gt;15	@A&gt; %&gt;N A ABS
15	induction	induction	obj:&gt;13	@OBJ %NH N NOM SG
16	.     .
</fdg>
</example>
</roleset>
</predicate>
</frameset>
